THOMSON Medical Group has priced its S$225 million senior notes due 2022 at 4.8 per cent, to be issued at par, the mainboard-listed healthcare provider said in a bourse filing late on Thursday....

THE following companies saw new developments that may affect trading of their shares on Friday:

THOMSON Medical Group has priced its S$225 million senior notes due 2022 at 4.8 per cent, to be issued at par, the mainboard-listed healthcare provider said late on Thursday night.

THE following companies saw new developments that may affect trading of their shares on Tuesday:

THOMSON Medical on Monday announced that it turned in a net loss of S$1.01 million for the first quarter - versus a net profit of S$89,000 a year ago - partly due to higher finance costs.

THOMSON Medical Group has appointed Wilson Sam as executive director and chief financial officer with effect from Friday.